The Financing of Illinois’ Prescription Drug Demonstration Project
This policy brief describes the financing of Illinois' new Medicaid prescription drug waiver.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This policy brief describes the financing of Illinois' new Medicaid prescription drug waiver.
Health News Index March/April, 2002 The March/April edition of the Kaiser Family Foundation/Harvard School of Public Health Health News Index includes questions about major health stories covered in the news, including the recent coverage of mammogram efficacy, the Institute of Medicine report on racial disparities in the health care system, and prescription drug discount cards.
The Medicare Chartbook includes data and background information critical to understanding the Medicare program and the challenges it faces in keeping up with the rising costs of health care and in ensuring the program s future financial security.
Summarizes the coverage of outpatient prescription drugs by Medicaid. Many low-income seniors and other Medicaid recipients rely on this benefit as their only means of drug coverage.
NPR/Kaiser Family Foundation/Harvard Kennedy School of Government Survey on Health Care A survey by NPR, the Kaiser Family Foundation, and Harvard s Kennedy School of Government finds that many Americans have real problems when it comes to accessing and paying for health care, and even if they haven't yet faced a problem, many worry about…
This brief analyzes changes in the new tax and budget reconciliation law that modify which drugs will be selected for Medicare drug price negotiation, which will lead to higher Medicare spending and higher costs for beneficiaries who take these medications.
This brief looks at premium changes for Medicare Part D stand-alone prescription drug plans between 2025 and 2026. For plans that were offered nationwide in 2025 and will continue to be offered in 2026, Part D enrollees in many states will see lower monthly premiums in 2026.
Some insurers in the ACA’s small group market are citing tariffs, particularly those affecting prescriptions drugs, as a reason for higher-than-expected premium increases.
People with disabilities are at risk in the health-care system because of their wide-ranging health-care needs, their relatively heavy use of prescription drugs, health-care and support services, and typically low incomes. A new survey of people with permanent mental and/or physical disabilities explores their health-care experiences and challenges in accessing and paying for care.
Retiree Health Benefits Now and In the Future - Report This survey, conducted by the Kaiser Family Foundation and Hewitt Associates between June and September 2003 provides detailed information on retiree health programs offered by large private-sector employers.
© 2026 KFF